Figure 2.

Therapeutic efficacy of blocking IL-6 activity in sJIA. IL, interleukin; sJIA, systemic onset juvenile idiopathic arthritis. Reprinted, with permission, from [19]. Copyright ^© 2005 American College of Rheumatology.